Company Filing History:
Years Active: 2025
Title: Eric Scott Lightcap: Innovator in Cancer Treatment
Introduction
Eric Scott Lightcap is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the administration of sting agonists and checkpoint inhibitors, which are crucial in the fight against cancer.
Latest Patents
Eric Scott Lightcap holds 1 patent for his invention titled "Administration of sting agonist and checkpoint inhibitors." This patent provides methods, pharmaceutical compositions, and kits for treating cancer in patients in need thereof. The methods comprise administering to a patient a STING (stimulator of interferon genes) agonist, such as Compound No. 14, or a pharmaceutically acceptable salt thereof, in combination with one or more checkpoint inhibitors. Suitable checkpoint inhibitors include anti-PD-1 antibodies, anti-PD-L1 antibodies, and anti-CTLA-4 antibodies. Additionally, the patent outlines medicaments for use in treating cancer.
Career Highlights
Eric Scott Lightcap is associated with Takeda Pharmaceutical Company Limited, where he continues to advance his research in oncology. His work has the potential to significantly impact cancer treatment protocols and improve patient outcomes.
Collaborations
Eric collaborates with Yosuke Sato, contributing to the development of innovative cancer therapies.
Conclusion
Eric Scott Lightcap is a dedicated inventor whose work in cancer treatment exemplifies the importance of innovation in medicine. His contributions through patents and collaborations are paving the way for new therapeutic approaches.